Joanna Horobin

2017 - Idera Pharmaceuticals

In 2017, Joanna Horobin earned a total compensation of $757.5K as Senior Vice President, Chief Medical Officer at Idera Pharmaceuticals, a 40% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$132,840
Option Awards$182,924
Salary$410,000
Other$31,754
Total$757,518

Horobin received $410K in salary, accounting for 54% of the total pay in 2017.

Horobin also received $132.8K in non-equity incentive plan, $182.9K in option awards and $31.8K in other compensation.

Rankings

In 2017, Joanna Horobin's compensation ranked 10,252nd out of 14,666 executives tracked by ExecPay. In other words, Horobin earned more than 30.1% of executives.

ClassificationRankingPercentile
All
10,252
out of 14,666
30th
Division
Manufacturing
3,973
out of 5,772
31st
Major group
Chemicals And Allied Products
1,397
out of 2,075
33rd
Industry group
Drugs
1,135
out of 1,731
34th
Industry
Biological Products, Except Diagnostic Substances
204
out of 313
35th
Source: SEC filing on April 25, 2019.

Horobin's colleagues

We found five more compensation records of executives who worked with Joanna Horobin at Idera Pharmaceuticals in 2017.

2017

Vincent Milano

Idera Pharmaceuticals

Chief Executive Officer

2017

Jonathan Yingling

Idera Pharmaceuticals

Chief Scientific Officer

2017

R Fletcher

Idera Pharmaceuticals

Senior Vice President, Business Development and Strategy

2017

Louis Arcudi

Idera Pharmaceuticals

Chief Financial Officer

2017

John Kirby

Idera Pharmaceuticals

Vice President of Finance, Principal Financial and Accounting Officer

News

You may also like